Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

March 30, 2015 6:15 AM ET

Healthcare Providers and Services

Company Overview of Navigenics, Inc.

Executive Profile

Sean E. George Ph.D.

Co-Founder, President, Chief Operating Officer, Member of Strategy Team and Director, Invitae Corporation
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Sean E. George, Ph.D. is Co-Founder of InVitae Corporation and serves as its Member of Strategy Team and also has been its President and Chief Operating Officer since August 2008. Dr. George has held a number of executive management positions in the life science industry. He served as Chief Operating Officer of Navigenics, Inc. He was Co-Founder and Chief Executive Officer of Locus Development Inc. Dr. George served as the President at Locus Development Inc. Dr. ...

Corporate Headquarters

405 North Wilmington Avenue
Compton, California 90220

United States

Phone: 800-917-6090
Fax: --

Board Members Memberships

President and Director
Co-Founder, President, Chief Operating Officer, Member of Strategy Team and Director


University of California-Los Angeles
University of California, Santa Barbara
University of California, Santa Cruz

Other Affiliations

Annual Compensation

Total Annual Compensation$281,857

Stocks Options

Exercisable Options$19,444
Exercisable Options Value$247,717
Unexercisable Options$113,889
Unexercisable Options Value$970,946
Total Value of Options$1,218,662
Total Number of Options$133,333

Total Compensation

Total Annual Cash Compensation$281,857
Total Short Term Compensation$281,857
Total Calculated Compensation$736,212

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Peter D. Meldrum Ph.D.Chief Executive Officer, President and Director
Myriad Genetics Inc.
Stephen H. Rusckowski Chief Executive Officer, President and Director
Quest Diagnostics Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Navigenics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at